Novophage Lands Series A Round
Early-stage industrial biologics company Novophage completed a $5.7 million Series A round of financing. The round was led by Flybridge Capital Partners and included Chevron Technology Ventures, Founder Collective, The Kraft Group and Boston University. As part of the funding, Founder Collective's Micah Rosenbloom has joined the company as CEO.
31 May 2011•4 mins read
